FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
